OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2026-03-31-accounts

Charity Registration No. 293108

THE JEAN SHANKS FOUNDATION

ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

THE JEAN SHANKS FOUNDATION

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees Mr Eric Rothbarth
Dr Julian Axe
Professor Sir James Underwood
Professor Sir Nicholas Wright
Mr Alistair Jones
Professor Adrienne Flanagan
Professor Mark Arends
Professor E. Anne MacGregor
Professor Humphrey Hodgson
Dr Helen Louise Munn OBE (Appointed 7 May 2026)
Charity number 293108
Principal address Peppard Cottage
Peppard Common
Henley on Thames
Oxon
United Kingdom
RG9 5LB
Auditor HW Fisher Audit
Acre House
11-15 William Road
London
United Kingdom
NW1 3ER
Bankers Coutts & Co
440 Strand
London
United Kingdom
WC2R 0QS
Lloyds Banking Group PLC
25 Gresham Street
London
EC2V 7HN
Solicitors Russell Cooke LLP
2 Putney Hill
London
SW15 6AB
Investment advisors Cazenove Capital
Regency Court
Glategny Esplanade
St Peter Port
Guernsey
GY1 3UF

THE JEAN SHANKS FOUNDATION

CONTENTS

Page
Trustees' report 1 - 4
Statement of trustees' responsibilities 5
Independent auditor's report 6 - 8
Statement of financial activities 9
Balance sheet 10
Statement of cash flows 11
Notes to the financial statements 12 - 18

THE JEAN SHANKS FOUNDATION

TRUSTEES' REPORT

FOR THE YEAR ENDED 31 MARCH 2026

The Trustees present their report and financial statements for the year ended 31 March 2026.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the Foundation's Trust Deed, the Charities Act 2011 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)".

Objectives and activities

The objects of the Foundation are to ensure the advancement and promotion of medical research and education, the dissemination of the results of such research, and the establishment and maintenance of scholarship grants to be awarded to scientists and other people or establishments involved in branches of medical and related sciences.

The Foundation provides research awards in the general medical field but primarily in pathology, and funds research and other projects where appropriate and in keeping with its aims.

All of the Foundation's objects are recognised by English law to be exclusively charitable.

The Trustees meet regularly with the Foundation's investment advisors to evaluate the performance of its portfolio.

The Foundation does not employ any personnel.

Achievements and performance

During the year the Foundation's investments performed in line with many other charity portfolios. The Foundation had investment income of £638,992 (2025: £609,405) and a net gain in value of investments of £4,053,918 (2025: £257,272).

Cazenove Capital Management, an investment manager, advise and manage the funds and invest these funds with the aim of generating, on average, the sum of 4% (2024: 4%) plus consumer purchase index annual return and losses of no more than 15% (2024: 15%) in any one year.

The Foundation made 16 grants totaling £470,059 (2025: 18 totaling £421,469). The Trustees aim to make grants to more individuals who are doing research at leading medical institutions. A few applicants who were offered our grants simultaneously secured funding from other sources such as the Medical Research Council or CRUK. This confirms that we are approving candidates assessed externally as being of the highest quality. The Foundation is making awards in a joint scheme with the Pathological Society of Great Britain and Ireland. Two awards were made at the PhD level which were then turned down as the awardees were made a similar award by another prestigious benefactor. The Trustees were disappointed but delighted that our awards are competing with much bigger organisations.

The Foundation reviewed the 2018 agreement with the Pathological Society of Great Britain and Ireland and concluded that the grants made were worthwhile and effective and the joint venture funding was being used correctly, for the benefits outlined in the Trust Agreement. and within the confines of the joint venture funding agreement. The Trustees agreed to extend the agreement for a further 5-year term committing to jointly fund a further £5 million for similar projects with the Pathological Society with effect from 1 January 2023. These projects will continue until about 2031 as some projects are for three years.

Reports by the awardee are provided annually for all grants and are reviewed by the Foundation and the Pathological Society and a decision is made as to whether to continue funding the grant in the event they last more than 12 months. To date no grants have been terminated early due to non-performance or failure to provide an adequate report by the recipient.

The Foundation has made a good start to the current financial year and remains conservatively invested in the global markets. The impact of the wars in the Middle East have reduced the value of our investments from the peak in February 2026 at the year end but not materially. This has since recovered and increased substantially in value.

The Finance Committee met and communicated regularly and also meet with the investment advisors on at least two occasions each year. The investment advisors have attended one Trustee meeting during the year to 31 March 2026.

THE JEAN SHANKS FOUNDATION

TRUSTEES' REPORT (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2026

Financial review

For the year ended 31 March 2026, the results show a total net gain in funds of £4,097,222 (2025: £289,858) and net assets of £33,220,874 (2025: £29,123,652).

The incoming funds were received from the portfolio managed by Messrs Cazenove Capital as investment income of £580,534 (2025: £531,142). The charity had valuation gains on its portfolio amounting to £4,053,918 (2024: £257,272).

Expenditure on governance costs amounted to £18,798 (2025: £23,456), investment management charges amounted to £98,867 (2025: £91,684) and legal and professional fees amounted to £28,877 (2025: £26,633). These costs combined (being investments management fees, legal charges and governance costs) represent 0.44% (2025: 0.49%) of the fund. The investment management fee is due to the legislation regarding commissions payable to advisers which means that the Foundation pays 0.3% commission on its portfolio valuation in addition to the fees charged by the fund managers. Both are deducted from the fund annually before being reported to the Foundation. The overall management fee cost is approximately 1.25% after fund management fees are included. The charitable grants made to medical institutions are shown in Note 6 to the financial statements amounting to £435,424 (2025: £421,469).

Reserves policy

The Trustees have carefully considered the minimum amount of reserves that they should hold, having taken into account that they wish the Foundation to continue for the long term, as well as the annual commitments that the Foundation has made and wishes to make in the future. The foundation's policy is to distribute substantially all its income. The invested assets are in effect, a financial reserve. The grants made in recent financial years have been broadly equivalent to the foundation's income. It is planned that this level of expenditure can be maintained in the future with a minimum amount of reserves at £15m. This level of reserves was maintained throughout the year.

Grant Making Policy

The grants, jointly funded with the Pathological Society of Great Britain and Ireland, continue and are progressing well. The take up has been slower than anticipated but is now moving towards the level that was initially predicted. The level of grants made has also been affected by the Pathological Society restricting the grants awarded so that we do not exceed the committed amounts for each party. The Foundation will make more awards in its own right in the future if suitable candidates are found. The main grants are made jointly with the Pathological Society and can be found on the Pathological Society website (see below).

The Grant is recognised in the financial statements when the recipient is informed in writing that they have been selected to receive the grant and the recipient confirms their willingness to accept the award. The expenditure is recognised as incurred and offset against the total liability of that grant. The Foundation acknowledges its share of the award when the offer is made and accepted.

The grants that are currently available are included on the Pathological Society website www.pathsoc.org/grants_lectures_awards/ research and include grants for Pre-Doctoral Research Bursary; Clinical Lecturer Grant, Clinical Lecturer Support, Intermediate Research Fellowship, PhD grants as well as grants for students to do a short spell in a pathology environment as an introduction to the science.

The current grants are:

THE JEAN SHANKS FOUNDATION

TRUSTEES' REPORT (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2026

Future grants

In 2018 the Foundation decided that grants should be more focused on promoting clinical academic careers, specialising in pathology with an emphasis on histopathology. Therefore, the Foundation agreed with the Pathological Society of Great Britain and Ireland to each fund £2,500,000 in the five years to 2023 to develop bursaries which include pre-doctoral academic clinical fellowships, clinical PhD fellowships, clinical lecturer support and clinical intermediate fellowships. This agreement has been extended for a further 5 years from 2023 where each party contributes £2,500,000 over that period. Both parties believe that this will grow during the course of this financial year as more suitably qualified candidates are found and accept our offer to fund research. The Foundation will make more awards in its own right in the future if suitable candidates are found.

The Foundation will also continue to make grants for other purposes at its discretion provided they are within its remit.

Trustees' induction, training and remuneration

The Trustees are selected because of their skills in either medicine or their speciality in administration, finance or law.

The Trustees are or have been trustees of other charities. The medical trustees receive training from the conferences etc. that they attend. The non-medical Trustees also attend courses offered by Cazenove Capital and other relevant courses.

The Trustees are not remunerated other than Eric Rothbarth who deals with the day to day matters of the Foundation and manages the Foundation with respect to all its activities (fund managers, banking relationships, legal and audit as well as the website, IT needs, applications for grants) and the Foundation’s relations with its stakeholders.

Risk and mitigation

The Trustees consider the major risks to which the Foundation may be exposed and discusses these at each board meeting.

The key risk relates to a potential loss of income or capital due to fluctuations in investment markets, which is mitigated by employing experienced and well-regarded investment managers and giving them a clear mandate of strategy and benchmark, and regular review points. This risk is under scrutiny, as the markets are being influenced by the world economic crisis, political turmoil and continued high inflation. Trustees take a long-term view on investments, and believe that the mitigations to minimise the impact seem to be appropriate. Trustees continue to monitor this area at every trustee meeting.

Investment policy

The Trustees regularly review their investment strategy and have agreed the following guidelines for their investment managers. The objective is to receive an average investment return of 4% plus consumer price index per annum in money terms over the longer term. The constraints are that:

  1. There is no great requirement for liquidity but the Foundation will maintain liquid reserves to cover at least one year's grant payments and any commitments for longer term grants.

  2. The portfolio should be managed on a total (capital and income) return basis but with a minimum annual distribution to match the income generated (excluding capital gains).

  3. The Trustees are looking at a medium term time horizon being 3-7 years.

  4. The Trustees employ Messrs. Cazenove Capital, a firm of investment managers, to manage the portfolio. This firm is a subsidiary of Schroder & Co and there has been no change in investment managers other than the name.

At 31 March 2026, £543,398 (2025: £71,004) of the charity's cash was held by Messrs. Cazenove Capital as part of the investment portfolio. A further £266,955 (2025: £260,168) was held in a 90-day notice account, £500 (2025: £500) in a current account and £1,522 (2025: £2,330) in a reserve account at Coutts. A further £1,134 (2025: £2,881) was held at Lloyds Banking Group PLC. A Reserve Account at Lloyds Bank Group PLC, held £219,089 (2025: £127,604) at the year end.

THE JEAN SHANKS FOUNDATION

TRUSTEES' REPORT (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2026

Structure, governance and management

The Jean Shanks Foundation is constituted by a charitable trust deed dated 11 November 1985 and is registered with the Charity Commission (No. 293108).

The Trustees who served during the year and up to the date of approval of the financial statements were: Mr Eric Rothbarth Dr Julian Axe Professor Sir James Underwood Professor Sir Nicholas Wright Mr Alistair Jones Professor Adrienne Flanagan Professor Mark Arends Professor E. Anne MacGregor Professor Humphrey Hodgson Dr Helen Louise Munn OBE (Appointed 7 May 2026)

The power of appointing new or additional Trustees is vested in the Board of Trustees. The Trustees meet at least twice yearly to assess grant applications, review current and ongoing projects and to review the Foundation's investment portfolio and agree future funding and strategy.

The Trustees are responsible for deciding the overall strategy of the Foundation and monitoring progress. One Trustee (Mr Eric Rothbarth) is delegated by the Board of Trustees to manage the day-to-day operation of the charity as the Managing Trustee.

Public benefit

The sections of this report above entitled "Objectives and Activities" and "Achievements and Performance" set out The Jean Shanks Foundation's objectives, and report on the activity and successes in the year to 31 March 2026, as well as explaining the plans for the current financial year. The Jean Shanks Foundation's work benefits medical practitioners and medical specialists in carrying further research to further medicine and cures for present and new diseases.

The Trustees have paid due regard to guidance issued on public benefit by the Charity Commission in deciding what activities the Foundation should undertake.

The Trustees have considered the extent to which these activities are of benefit to the public and concluded:

On behalf of the Board of Trustees

..............................

Mr Eric Rothbarth

Trustee Dated: .........................01 Oct 2026

THE JEAN SHANKS FOUNDATION

STATEMENT OF TRUSTEES' RESPONSIBILITIES

FOR THE YEAR ENDED 31 MARCH 2026

The trustees are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

The law applicable to charities in England and Wales requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Foundation and of the incoming resources and application of resources of the Foundation for that year.

In preparing these financial statements, the trustees are required to:

The trustees are responsible for keeping sufficient accounting records that disclose with reasonable accuracy at any time the financial position of the Foundation and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the trust deed. They are also responsible for safeguarding the assets of the Foundation and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

THE JEAN SHANKS FOUNDATION

INDEPENDENT AUDITOR'S REPORT

TO THE TRUSTEES OF THE JEAN SHANKS FOUNDATION

Opinion

We have audited the financial statements of The Jean Shanks Foundation (the ‘Foundation’) for the year ended 31 March 2026 which comprise the statement of financial activities, the balance sheet, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the Foundation in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Foundation’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters in relation to which the Charities (Accounts and Reports) Regulations 2008 requires us to report to you if, in our opinion:

THE JEAN SHANKS FOUNDATION

INDEPENDENT AUDITOR'S REPORT (CONTINUED)

TO THE TRUSTEES OF THE JEAN SHANKS FOUNDATION

Responsibilities of trustees

As explained more fully in the statement of trustees' responsibilities, the trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the trustees are responsible for assessing the Foundation’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

We have been appointed as auditor under section 144 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

As part of our planning process:

The key procedures we undertook to detect irregularities including fraud during the course of the audit included:

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements even though we have properly planned and performed our audit in accordance with auditing standards. The primary responsibility for the prevention and detection of irregularities and fraud rests with the trustees of the charity.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/ auditorsresponsibilities. This description forms part of our auditor's report.

THE JEAN SHANKS FOUNDATION

INDEPENDENT AUDITOR'S REPORT (CONTINUED)

TO THE TRUSTEES OF THE JEAN SHANKS FOUNDATION

Use of our report

This report is made solely to the charity’s trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to the charity’s trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.

HW Fisher Audit

HW Fisher Audit

Chartered Accountants Statutory Auditor Acre House 11-15 William Road London NW1 3ER United Kingdom

.........................01 Oct 2026

THE JEAN SHANKS FOUNDATION

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 MARCH 2026

Unrestricted Unrestricted
funds funds
2026 2025
Notes £ £
Income from:
Investments 3 638,992 609,405
Total income 638,992 609,405
Expenditure on:
Raising funds 4 98,867 91,684
Charitable activities 5 496,821 485,135
Total expenditure 595,688 576,819
Net gains/(losses) on investments 10 4,053,918 257,272
Net income and movement in funds 4,097,222 289,858
Reconciliation of funds:
Fund balances at 1 April 2025 29,123,652 28,833,794
Fund balances at 31 March 2026 33,220,874 29,123,652

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

THE JEAN SHANKS FOUNDATION

BALANCE SHEET

AS AT 31 MARCH 2026

2026
Notes
£
£
Fixed assets
Investments
11
34,098,252
Current assets
Debtors
12
90,921
Cash at bank and in hand
489,201
580,122
Creditors: amounts falling due within one year
13
(1,156,556)
Net current liabilities
(576,434)
Total assets less current liabilities
33,521,818
Creditors: amounts falling due after more than
one year
14
(300,944)
Net assets
33,220,874
Income funds
Unrestricted funds
33,220,874
33,220,874
The financial statements were approved by the Trustees on .........................
..............................
..............................
Mr Eric Rothbarth
Professor Sir James Underwood
Trustee
Trustee
01 Oct 2026
2025
£
45,410
393,483
438,893
(1,423,549)
£
30,518,872
(984,656)
29,534,216
(410,564)
29,123,652
29,123,652
29,123,652

THE JEAN SHANKS FOUNDATION

STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 MARCH 2026

Notes
Cash flows from operating activities
Cash absorbed by operations
16
Investing activities
Cash withdrawn from operating activities
Investment income received
Net cash generated from investing activities
Net cash used in financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
2026
£
1,000,000
16,989
£
(921,271)
1,016,989
-
95,718
393,483
489,201
2025
£
550,000
10,731
£
(439,594)
560,731
-
121,137
272,346
393,483

THE JEAN SHANKS FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

1 Accounting policies

Charity information

The Jean Shanks Foundation is a registered charity.

1.1 Accounting convention

The financial statements have been prepared in accordance with the Foundation's Trust Deed, the Charities Act 2011 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)". The Foundation is a Public Benefit Entity as defined by FRS 102.

The financial statements are prepared in sterling, which is the functional currency of the Foundation. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2 Going concern

The trustees believe that the Foundation has adequate resources, which include a significant investment portfolio, to be able to continue its activities for the foreseeable future. Thus, the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

All of the Foundation's funds are unrestricted funds, which are available for use at the discretion of the trustees in furtherance of their charitable objectives.

1.4 Incoming resources

Income is recognised when the Foundation is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Interest on funds held on deposit is included upon notification of the interest paid or payable by the Bank. Dividends are recognised once the dividend has been declared and notification has been received by our investment advisor of the investment portfolio.

1.5 Resources expended

Liabilities are recognised as expenditure once there is a legal or constructive obligation committing the charity to that expenditure, it is probable that settlement will be required and the amount of the obligation can be measured reliably.

All expenditure is accounted for on an accruals basis. All expenses, including support costs and governance costs, are allocated to the charitable activity in the statement of financial activities.

Costs of raising funds are those costs incurred in managing the Foundation's investment portfolio.

Grants payable are payments made to third parties in the furtherance of the charitable objects of the charity. In the case of an unconditional grant offer this is accrued once the recipient has been notified of the grant award. The notification gives the recipient a reasonable expectation that they will receive the one year or multi-year grant. Grant awards that are subject to the recipient fulfilling performance conditions are only accrued when the recipient has been notified of the grant and any remaining unfulfilled conditions attaching to that grant are outside of the control of the charity. Where no conditions exist, the full grant payable is recognised in the year the grant offer has been communicated.

Provisions for grants are made when the intention to make the grant has been communicated to the recipient but there is uncertainty as to the timing of the grant or the amount of grant payable.

THE JEAN SHANKS FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2026

1 Accounting policies

(Continued)

A provision for a multi-year grant is recognised at its present value where settlement is due over more than one year from the date of the award, there are no unfulfilled performance conditions under the control of the charity that would permit the charity to avoid making the future payments, settlement is probable, and the effect of discounting is material. The discount rate used is the rate offered on government bonds (Gilts) for a commensurate or similar time period offered in the year in which the grant award is made.

Governance costs comprise all costs involving the public accountability of the charity and its compliance with regulation and good practice.

Irrecoverable VAT is charged against the expenditure heading for which it was incurred.

1.6 Financial instruments

The Foundation has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Foundation's balance sheet when the Foundation becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Investments are a form of basic financial instrument and are initially recognised at their transaction value and subsequently measured at their fair value as at the balance sheet date using the closing quoted market price. The statement of financial activities includes the net gains and losses arising on revaluation and disposals throughout the year.

The Foundation does not acquire put options, derivatives or other complex financial instruments.

Basic financial liabilities

Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities.

THE JEAN SHANKS FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2026

2 Critical accounting estimates and judgements

In the application of the Foundation’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

The Trustees do not believe there to be any judgements or estimates that would be considered critical to the financial statements.

3 Income from investments

Unrestricted Unrestricted
funds funds
2026 2025
£ £
Income from listed investments 580,534 531,142
Interest receivable 58,458 78,263
638,992 609,405

4 Raising funds

Unrestricted Unrestricted
funds funds
2026 2025
£ £
Investment management 98,867 91,684
98,867 91,684

THE JEAN SHANKS FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2026

5 Charitable activities

Medical Research and Education
Secretarial expenses
Office & travel expenses
Legal and professional
Bank Charges
Grant funding of activities (see note 6)
Share of governance costs (see note 7)
2026
£
1,000
11,993
28,877
729
42,599
435,424
18,798
496,821
2025
£
1,000
11,957
26,633
620
40,210
421,469
23,456
485,135

6 Grants payable

Grants to institutions:
University of Southampton
University College London
Academy of Medical Sciences
Institute of Cancer Research
Grand Rounds through Pathological Society
University of Glasgow
National Academic Residents' Network Meeting through Pathological Society
Student Scholarships through Pathological Society
University of Oxford
University of Leeds
During the year, 16 grants were made to institutions (2025: 18).
Reconciliation of grants payable
Commitments as at 1 April 2025
Commitments made in the year
Grants paid during the year
Commitments as at 31 March 2026
Total
2026
£
147,412
98,900
30,000
-
1,894
25,000
1,015
2,200
163,638
(34,635)
435,424
2026
£
1,764,574
435,424
(848,122)
1,351,876
Total
2025
£
-
109,950
30,000
50,000
3,000
-
5,280
223,239
-
421,469
2025
£
1,722,858
421,469
(379,753)
1,764,574

THE JEAN SHANKS FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2026

7 Support costs allocated to activities


Governance
Governance costs comprise:
Audit fees
Accountancy
Charitable
activities
2026
£
18,798
2026
£
15,648
3,150
18,798
Total
2025
£
23,456
2025
£
19,200
4,256
23,456

8 Trustees

None of the trustees (or any persons connected with them) received any remuneration during the year with the exception of Mr Eric Rothbarth who was paid a fee of £25,000 (2024: £25,000) for his services managing the Foundation on a day to day basis. Five trustees (2025: five) were reimbursed a total of £3,075 (2025: £5,888) for travel and office expenses.

9 Employees

There were no employees during the current or prior year.

10 Gains and losses on investments

Unrestricted Unrestricted
funds funds
2026 2025
Gains/(losses) arising on: £ £
Revaluation of investments 3,518,505 138,869
Sale of investments 535,413 118,403
4,053,918 257,272

THE JEAN SHANKS FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2026

11 Fixed asset investments

Listed
investments
Cash
£
Cost or valuation
At 1 April 2025
30,447,868
Additions
7,080,241
Valuation changes
3,518,505
Cash withdrawn
-
Investment Management Fees
-
Dividends and interest received
-
Disposals
(7,491,760)
At 31 March 2026
33,554,854
Carrying amount
At 31 March 2026
33,554,854
At 31 March 2025
30,447,868
12
Debtors
Amounts falling due within one year:
Other debtors
Prepayments and accrued income
13
Creditors: amounts falling due within one year
Grants payable
Accruals
14
Creditors: amounts falling due after more than one year
Grants Payable
in portfolio
£
71,004
(7,080,241)
-
(1,000,000)
(96,541)
622,003
8,027,173
543,398
543,398
71,004
2026
£
34,635
56,286
90,921
2026
£
1,085,567
70,989
1,156,556
2026
£
300,944
Total
£
30,518,872
-
3,518,505
(1,000,000)
(96,541)
622,003
535,413
34,098,252
34,098,252
30,518,872
2025
£
-
45,410
45,410
2025
£
1,354,010
69,539
1,423,549
2025
£
410,564

THE JEAN SHANKS FOUNDATION

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2026

15 Related party transactions

At 31 March 2026, Mr Eric Rothbarth was owed £25,000 (2025: £25,000) by the Foundation.

At year-end, included within grants payable is £1,386,511 (2025: £1,764,574). These amounts represent grants which are payable to The Pathological Society of Great Britain & Ireland, who then pays these amounts to the institutions, under the terms of agreement. Under this agreement, The Foundation and The Pathological Society of Great Britain & Ireland share grants payable 50/50. Professor Mark Arends, a trustee of the Foundation, is a Trustee and General Secretary of the Pathological Society of Great Britain & Ireland.

16
Cash generated from operations
2026
£
Surplus for the year
4,097,222
Adjustments for:
Investment income recognised in statement of financial activities
(638,992)
Gain on disposal of investments
(535,413)
Fair value gains and losses on investments
(3,518,505)
Investment management fees from portfolio
96,541
Movements in working capital:
(Increase) in debtors
(45,511)
(Decrease)/increase in creditors
(376,613)
Cash absorbed by operations
(921,271)
2025
£
289,858
(609,405)
(118,403)
(138,869)
89,574
-
47,651
(439,594)

17 Analysis of changes in net funds

The Foundation had no debt during the year.